KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Liabilities and Shareholders Equity (2016 - 2025)

CareDx's Liabilities and Shareholders Equity history spans 13 years, with the latest figure at $413.2 million for Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity fell 15.85% year-over-year to $413.2 million; the TTM value through Dec 2025 reached $1.8 billion, down 5.71%, while the annual FY2025 figure was $413.2 million, 15.85% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $413.2 million at CareDx, down from $432.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $566.6 million in Q4 2021 and bottomed at $413.2 million in Q4 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $508.0 million (2023), against an average of $504.1 million.
  • The largest annual shift saw Liabilities and Shareholders Equity soared 245.2% in 2021 before it dropped 15.85% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $566.6 million in 2021, then fell by 4.17% to $543.0 million in 2022, then decreased by 14.03% to $466.8 million in 2023, then grew by 5.19% to $491.0 million in 2024, then dropped by 15.85% to $413.2 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Liabilities and Shareholders Equity are $413.2 million (Q4 2025), $432.3 million (Q3 2025), and $444.3 million (Q2 2025).